Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan.
Atherosclerosis. 2012 Apr;221(2):521-6. doi: 10.1016/j.atherosclerosis.2012.01.001. Epub 2012 Jan 12.
Although inhibition of Rho-associated coiled-coil containing protein kinase (ROCK) has been shown to prevent coronary vasospastic angina (CVA), direct evidence linking ROCK activity and CVA is lacking. Accordingly, we investigated whether ROCK activity is an independent marker for CVA and is altered after treatment with antispastic medications.
We prospectively studied 31 Taiwanese patients who were diagnosed with CVA and 33 control subjects. Subject demographics were recorded, and blood samples were obtained at baseline in all participants and in CVA patients after 3 months of antispastic treatment. Compared with control subjects, leukocyte ROCK activity was greater in CVA patients (136% versus 91%, P<0.001). A cutoff value for leukocyte ROCK activity of 104% predicted the presence of CVA with specificity and sensitivity rates of 88% and 84%, respectively. ROCK activity increased with the severity of CVA (P for trend<0.001). Following 3-month treatment of antispastic agents, leukocyte ROCK activity, high-sensitivity C-reactive protein, and interleukin-6 levels were reduced by 43%, 42% and 27%, respectively (P<0.05 for all).
Increased levels of leukocyte ROCK activity independently predicted the presence of CVA and correlated with CVA severity. Treatment with antispastic agents substantially reduced the level of leukocyte ROCK activity.
尽管 Rho 相关卷曲螺旋蛋白激酶(ROCK)抑制已被证实可预防冠状动脉痉挛性心绞痛(CVA),但与 CVA 相关的 ROCK 活性的直接证据仍然缺乏。因此,我们研究了 ROCK 活性是否为 CVA 的独立标志物,以及在抗痉挛药物治疗后是否发生改变。
我们前瞻性研究了 31 例被诊断为 CVA 的台湾患者和 33 例对照者。记录了受试者的人口统计学数据,并在所有参与者和 CVA 患者接受 3 个月抗痉挛治疗后获得了基线时的血液样本。与对照组相比,CVA 患者的白细胞 ROCK 活性更高(136%比 91%,P<0.001)。白细胞 ROCK 活性的截断值为 104%,预测 CVA 的特异性和敏感性分别为 88%和 84%。ROCK 活性随 CVA 的严重程度而增加(趋势 P<0.001)。在接受抗痉挛药物治疗 3 个月后,白细胞 ROCK 活性、高敏 C 反应蛋白和白细胞介素-6 水平分别降低了 43%、42%和 27%(P<0.05)。
白细胞 ROCK 活性升高可独立预测 CVA 的存在,并与 CVA 严重程度相关。抗痉挛药物治疗可显著降低白细胞 ROCK 活性。